Atsuko Umezawa

440 total citations
12 papers, 320 citations indexed

About

Atsuko Umezawa is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Atsuko Umezawa has authored 12 papers receiving a total of 320 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Oncology and 4 papers in Epidemiology. Recurrent topics in Atsuko Umezawa's work include Neuroendocrine Tumor Research Advances (4 papers), DNA Repair Mechanisms (2 papers) and Renal and related cancers (2 papers). Atsuko Umezawa is often cited by papers focused on Neuroendocrine Tumor Research Advances (4 papers), DNA Repair Mechanisms (2 papers) and Renal and related cancers (2 papers). Atsuko Umezawa collaborates with scholars based in Japan and China. Atsuko Umezawa's co-authors include Isao Okayasu, Shi‐Xu Jiang, Toru Kameya, Makoto Saegusa, Tetuo Mikami, Yuichi Sato, Hisao Asamura, Kanji Nagai, Toru Igarashi and Yasuaki Kawakubo and has published in prestigious journals such as International Journal of Cancer, The American Journal of Surgical Pathology and Cancer Letters.

In The Last Decade

Atsuko Umezawa

12 papers receiving 313 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Atsuko Umezawa Japan 8 181 126 106 97 63 12 320
Mei-Fang Zhang China 8 155 0.9× 94 0.7× 69 0.7× 174 1.8× 20 0.3× 9 347
Norishige Iizuka Japan 12 101 0.6× 78 0.6× 131 1.2× 157 1.6× 32 0.5× 27 399
Xuan Pei China 8 142 0.8× 102 0.8× 40 0.4× 120 1.2× 33 0.5× 17 311
Luka Ozretić Germany 8 344 1.9× 226 1.8× 105 1.0× 215 2.2× 52 0.8× 13 516
Julian Maurer Germany 11 155 0.9× 151 1.2× 31 0.3× 116 1.2× 85 1.3× 15 286
Taihei Kageyama Japan 10 82 0.5× 35 0.3× 60 0.6× 160 1.6× 16 0.3× 10 289
Anne‐Katrin Zimmermann Switzerland 9 139 0.8× 40 0.3× 91 0.9× 118 1.2× 11 0.2× 11 337
Anna‐Kaisa Eerola Finland 6 264 1.5× 57 0.5× 66 0.6× 182 1.9× 20 0.3× 7 407
Sunao Ushijima Japan 9 171 0.9× 51 0.4× 116 1.1× 156 1.6× 12 0.2× 14 349
Léopoldine Bricaire France 10 69 0.4× 67 0.5× 36 0.3× 95 1.0× 20 0.3× 19 293

Countries citing papers authored by Atsuko Umezawa

Since Specialization
Citations

This map shows the geographic impact of Atsuko Umezawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Atsuko Umezawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Atsuko Umezawa more than expected).

Fields of papers citing papers by Atsuko Umezawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Atsuko Umezawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Atsuko Umezawa. The network helps show where Atsuko Umezawa may publish in the future.

Co-authorship network of co-authors of Atsuko Umezawa

This figure shows the co-authorship network connecting the top 25 collaborators of Atsuko Umezawa. A scholar is included among the top collaborators of Atsuko Umezawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Atsuko Umezawa. Atsuko Umezawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Kato, Takuya, Yasutaka Sakurai, Masahiro Matsushita, et al.. (2023). REV7 is involved in outcomes of platinum‐based chemotherapy in pancreatic cancer by controlling the DNA damage response. Cancer Science. 115(2). 660–671. 2 indexed citations
2.
Hoshino, Akiyoshi, Shi‐Xu Jiang, Yasutaka Sakurai, et al.. (2021). Upregulation of REV7 correlates with progression of malignant melanoma. Pathology International. 72(1). 14–24. 7 indexed citations
3.
Sakurai, Yasutaka, Masaaki Ichinoe, Kazuki Yoshida, et al.. (2020). Inactivation of REV7 enhances chemosensitivity and overcomes acquired chemoresistance in testicular germ cell tumors. Cancer Letters. 489. 100–110. 20 indexed citations
4.
Sakurai, Yasutaka, Masaaki Ichinoe, Akiyoshi Hoshino, et al.. (2020). Increased expression of REV7 in small cell lung carcinomas and its association with tumor cell survival and proliferation. Pathology International. 71(1). 15–23. 6 indexed citations
5.
Ichinoe, Masaaki, Yasutaka Sakurai, Norihiro Nakada, et al.. (2016). CD109, a negative regulator of TGF-β signaling, is a putative risk marker in diffuse large B-cell lymphoma. International Journal of Hematology. 105(5). 614–622. 22 indexed citations
6.
Yanagisawa, Nobuyuki, et al.. (2015). High expression of REV7 is an independent prognostic indicator in patients with diffuse large B-cell lymphoma treated with rituximab. International Journal of Hematology. 102(6). 662–669. 19 indexed citations
7.
Umezawa, Atsuko, et al.. (2012). Total Vegetable Intake and Homegrown Vegetable Intake in the Rural Area Residents of Hokkaido. The Japanese Journal of Nutrition and Dietetics. 70(5). 283–293. 7 indexed citations
8.
Ishikawa, Midori, et al.. (2012). Changes in children’s consumption of tomatoes through a school lunch programme developed by agricultural high-school students. Health Education Journal. 72(5). 545–554. 1 indexed citations
9.
Jiang, Shi‐Xu, Kazuya Yamashita, Michiko Yamamoto, et al.. (2008). EGFR genetic heterogeneity of nonsmall cell lung cancers contributing to acquired gefitinib resistance. International Journal of Cancer. 123(11). 2480–2486. 72 indexed citations
10.
Jiang, Shi‐Xu, Tetuo Mikami, Atsuko Umezawa, et al.. (2006). Gastric Large Cell Neuroendocrine Carcinomas: A Distinct Clinicopathologic Entity. The American Journal of Surgical Pathology. 30(8). 945–953. 77 indexed citations
11.
Jiang, Shi-Xu, Toru Kameya, Hisao Asamura, et al.. (2004). hASH1 expression is closely correlated with endocrine phenotype and differentiation extent in pulmonary neuroendocrine tumors. Modern Pathology. 17(2). 222–229. 81 indexed citations
12.
Jiang, Shi‐Xu, Toru Kameya, Hisao Asamura, et al.. (2003). hASH1 expression is closely correlated with endocrine phenotype and differentiation extent in pulmonary neuroendocrine tumors. Modern Pathology. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mei-Fang Zhang Breakdown of academic impact, for papers by Norishige Iizuka Breakdown of academic impact, for papers by Xuan Pei Breakdown of academic impact, for papers by Luka Ozretić Breakdown of academic impact, for papers by Julian Maurer Breakdown of academic impact, for papers by Taihei Kageyama Breakdown of academic impact, for papers by Anne‐Katrin Zimmermann Breakdown of academic impact, for papers by Anna‐Kaisa Eerola Breakdown of academic impact, for papers by Sunao Ushijima Breakdown of academic impact, for papers by Léopoldine Bricaire
Rankless by CCL
2026